These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Long-term results after defibrinogenation by Arwin in chronic occlusive arterial disease. Staiger J; Konrad-Graf S; Keil G Bibl Haematol; 1981; (47):252-7. PubMed ID: 7337665 [No Abstract] [Full Text] [Related]
8. [Modified dosage scheme for the subcutaneous use of arvin in patients with chronic arterial occlusive diseases]. Ehrly AM; Köhler HJ Vasa; 1976; 5(2):155-62. PubMed ID: 973426 [No Abstract] [Full Text] [Related]
9. Treatment of severe intermittent claudication by controlled defibrination. Dormandy JA; Goyle KB; Reid HL Lancet; 1977 Mar; 1(8012):625-6. PubMed ID: 66429 [TBL] [Abstract][Full Text] [Related]
10. [Therapeutic defibrination by arwin in unstable angina pectoris combined with hyperfibrinogenaemia (author's transl)]. Spöttl F; Pimmingstorfer E; Froschauer J Wien Klin Wochenschr; 1978 Nov; 90(22):792-6. PubMed ID: 716435 [TBL] [Abstract][Full Text] [Related]
11. [Combination hemodilution and defibrinogenating therapy in chronic arterial occlusive diseases]. Ehrly AM; Saeger-Lorenz K Verh Dtsch Ges Kreislaufforsch; 1977; 43():332-3. PubMed ID: 349931 [No Abstract] [Full Text] [Related]
12. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis]. Ernst E MMW Munch Med Wochenschr; 1983 Sep; 125(37):796-8. PubMed ID: 6415441 [No Abstract] [Full Text] [Related]
13. SDS polyacrylamide gel characterization of serum FDP produced in response to ancrod and streptokinase/plasminogen infusion in man. Lane DA; Robbins A; Rampling MW; Kakkar VV Br J Haematol; 1977 May; 36(1):137-48. PubMed ID: 871418 [No Abstract] [Full Text] [Related]
14. Coagulation studies during therapeutic application of arvin. Vinazzer H Thromb Res; 1976 Feb; 8(2):243-8. PubMed ID: 943132 [No Abstract] [Full Text] [Related]
15. [Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin]. Ehrly AM Med Welt; 1975 Mar; 26(10):446-55. PubMed ID: 1123988 [No Abstract] [Full Text] [Related]
17. Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase. Clinical pharmacology and rheology. Forbes CD; Barbenell J; Prentice CR Haemostasis; 1976; 5(6):348-54. PubMed ID: 1017726 [TBL] [Abstract][Full Text] [Related]
18. [Defibrination in the therapy of arterial occlusive diseases]. Böhme H ZFA (Stuttgart); 1978 Nov; 54(32):1644-7. PubMed ID: 735319 [No Abstract] [Full Text] [Related]
19. Comparison of ancrod and heparin as anticoagulants following endarterectomy in the dog. Daniel TM; Pizzo SV; Mckee PA Ann Surg; 1976 Aug; 184(2):223-8. PubMed ID: 952568 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic lowering of fibrinogen levels]. Ernst E MMW Munch Med Wochenschr; 1983 May; 125(21):83-4. PubMed ID: 6410202 [No Abstract] [Full Text] [Related] [Next] [New Search]